A survey of across-target bioactivity results of small molecules in PubChem

National Center for Biotechnology Information, National Institutes of Health, Bethesda, MD 20894, USA.
Bioinformatics (Impact Factor: 4.98). 07/2009; 25(17):2251-5. DOI: 10.1093/bioinformatics/btp380
Source: PubMed


This work provides an analysis of across-target bioactivity results in the screening data deposited in PubChem. Two alternative
approaches for grouping-related targets are used to examine a compound's across-target bioactivity. This analysis identifies
compounds that are selectively active against groups of protein targets that are identical or similar in sequence. This analysis
also identifies compounds that are bioactive across unrelated targets. Statistical distributions of compound' across-target
selectivity provide a survey to evaluate target specificity of compounds by deriving and analyzing bioactivity profile across
a wide range of biological targets for tested small molecules in PubChem. This work enables one to select target specific
inhibitors, identify promiscuous compounds and better understand the biological mechanisms of target-small molecule interactions.

Contact: ywang{at}; bryant{at}

Download full-text


Available from: Yanli Wang
    • "" format. Notably, we added to this library the known AAC inhibitors such as CATR (taken from the crystallized BtAAC1 structure), ATR, BKA, and STE (taken from the pubchem database[47]) as reference inhibitors[4,24,30]. It should be stressed that in our library we used both the a-and b-D-glucosides for CATR. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mitochondrial carriers are proteins that shuttle a variety of metabolites, nucleotides and coenzymes across the inner mitochondrial membrane. The mitochondrial ADP/ATP carriers (AACs) specifically translocate the ATP synthesized within mitochondria to the cytosol in exchange for the cytosolic ADP, playing a fundamental role in energy production, in promoting cell viability and regulating mitochondrial permeability transition pore. In Homo sapiens four genes code for AACs with different tissue distribution and expression patterns. Since AACs are dysregulated in several cancer types, the employment of known and new AAC inhibitors might be crucial for inducing mitochondrial-mediated apoptosis in cancer cells. Albeit Carboxyatractyloside (CATR) and Bongkrekic acid (BKA) are known to be powerful and highly selective AAC inhibitors, able to induce mitochondrial dysfunction at molecular level and poisoning at physiological level, we estimated for the first time, their affinity for the human recombinant AAC2 by in vitro transport assays. We found that the inhibition constants of CATR and BKA are 4nM and 2.0μM, respectively. For finding new AAC inhibitors we also performed a docking-based virtual screening of an in-house developed chemical library and we identified about 100 ligands showing high affinity for the AAC2 binding region. By testing 13 commercially available molecules, out of the 100 predicted candidates, we found that 2 of them, namely suramin and chebulinic acid, are competitive AAC2 inhibitors with inhibition constants 0.3μM and 2.1μM, respectively. We also demonstrated that chebulinic acid and suramin are "highly selective" AAC2 inhibitors, since they poorly inhibit other human mitochondrial carriers (namely ORC1, APC1 and AGC1).
    No preview · Article · Nov 2015 · Biochemical pharmacology
  • Source
    • "The effects of small molecules on organisms have long been the focus of biochemistry and pharmacology. Over the last years there has been a considerable increase in the number of high-throughput screens that have been performed using chemical libraries (1–3). At the same time, the molecular targets of individual chemicals are being studied in ever greater detail (4,5). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Over the last years, the publicly available knowledge on interactions between small molecules and proteins has been steadily increasing. To create a network of interactions, STITCH aims to integrate the data dispersed over the literature and various databases of biological pathways, drug–target relationships and binding affinities. In STITCH 2, the number of relevant interactions is increased by incorporation of BindingDB, PharmGKB and the Comparative Toxicogenomics Database. The resulting network can be explored interactively or used as the basis for large-scale analyses. To facilitate links to other chemical databases, we adopt InChIKeys that allow identification of chemicals with a short, checksum-like string. STITCH 2.0 connects proteins from 630 organisms to over 74 000 different chemicals, including 2200 drugs. STITCH can be accessed at
    Full-text · Article · Nov 2009 · Nucleic Acids Research
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Binding interaction between ligand and G-protein coupled receptor plays an important role in the several steps of exertion of therapeutic effect by a drug and has become increasingly interesting to pharmacists, chemists, biologists and companies. α1-Adrenoceptor (α1-AR) was purified from cell line which stably expressed α1-AR and evenly immobilized on the surface of macroporous silica gel to prepare a novel stationary phase for investigating the interaction between drug and receptor. Control drugs of α1-AR including phentolamine, terazosin and urapidil were used to characterize the retention properties of the stationary phase containing the receptor. Further work was performed to calculate the binding sites and association constant of prazosin binding to the immobilized receptor. The results presented a value of 4.55 × 10−7 M−1 for binding sites and of 2.2 × 104 M for the association constant during the interaction between prazosin and α1-AR. The proposed affinity method was stable at least in seven consecutive days, as well as had the primary bioactivities of recognizing and binding the ligand, providing an alternative for representing the interaction between drug and functional protein.
    Full-text · Article · Apr 2012 · Chromatographia
Show more